Goldman Sachs
KURA icon

Goldman Sachs’s Kura Oncology KURA Stock Holding History

Goldman Sachs’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-70,000
Closed -$2.29M – 6220
2020
Q4 		$2.29M Buy
+70,000
New +$2.46M ﹤0.01% 3629

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Goldman Sachs's KURA Position: Q2 2026 in Review

Goldman Sachs increased its Kura Oncology (KURA) stake by 58% in Q2 2026, buying an estimated $7.85M and bringing the position to 2,265,171 shares worth $24.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2426.

Goldman Sachs first reported a position in KURA in Q1 2016 and has held it in 39 quarters since. The position peaked at $41M in Q4 2020. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Goldman Sachs held 2,265,171 shares of Kura Oncology worth $24.8M as of Q2 2026.
  • Goldman Sachs bought 831,700 Kura Oncology shares in Q2 2026, an estimated $7.85M.
  • Kura Oncology made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2426 holding.
  • Goldman Sachs first reported a position in Kura Oncology in Q1 2016 and has held it in 39 quarters since.
  • Goldman Sachs's Kura Oncology position peaked at $41M in Q4 2020.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.